Regulation of expanded polyglutamine protein aggregation and nuclear localization by the glucocorticoid receptor

Marc I. Diamond^*,, Melissa R. Robinson, and Keith R. Yamamoto^,

Departments of ^*Neurology and Cellular and Molecular Pharmacology, and School of Medicine, University of California, San Francisco, CA 94143

Accepted for publication November 23, 1999.

Abstract: Spinobulbar muscular atrophy and Huntington's disease are caused by polyglutamine expansion in the androgen receptor and huntingtin, respectively, and their pathogenesis has been associated with abnormal nuclear localization and aggregation of truncated forms of these proteins. Here we show, in diverse cell types, that glucocorticoids can up- or down-modulate aggregation and nuclear localization of expanded polyglutamine polypeptides derived from the androgen receptor and huntingtin through specific regulation of gene expression. Wild-type glucocorticoid receptor (GR), as well as C-terminal deletion derivatives, suppressed the aggregation and nuclear localization of these polypeptides, whereas mutations within the DNA binding domain and N terminus of GR abolished this activity. Surprisingly, deletion of a transcriptional regulatory domain within the GR N terminus markedly increased aggregation and nuclear localization of the expanded polyglutamine proteins. Thus, aggregation and nuclear localization of expanded polyglutamine proteins are regulated cellular processes that can be modulated by a well-characterized transcriptional regulator, the GR. Our findings suggest approaches to study the molecular pathogenesis and selective neuronal degeneration of polyglutamine expansion diseases.

Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.

H. L. Montie, M. S. Cho, L. Holder, Y. Liu, A. S. Tsvetkov, S. Finkbeiner, and D. E. Merry (2009)
Hum. Mol. Genet. 18, 1937-1950
 |  Abstract »  |  Full Text »  |  PDF »

Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Huntington's Disease.

N. A. Aziz, H. Pijl, M. Frolich, A. W. M. van der Graaf, F. Roelfsema, and R. A. C. Roos (2009)
J. Clin. Endocrinol. Metab. 94, 1223-1228
 |  Abstract »  |  Full Text »  |  PDF »

Phosphorylation of Profilin by ROCK1 Regulates Polyglutamine Aggregation.

J. Shao, W. J. Welch, N. A. DiProspero, and M. I. Diamond (2008)
Mol. Cell. Biol. 28, 5196-5208
 |  Abstract »  |  Full Text »  |  PDF »

A Common Motif Targets Huntingtin and the Androgen Receptor to the Proteasome.

S. Chandra, J. Shao, J. X. Li, M. Li, F. M. Longo, and M. I. Diamond (2008)
J. Biol. Chem. 283, 23950-23955
 |  Abstract »  |  Full Text »  |  PDF »

Polyglutamine diseases: emerging concepts in pathogenesis and therapy.

J. Shao and M. I. Diamond (2007)
Hum. Mol. Genet. 16, R115-R123
 |  Abstract »  |  Full Text »  |  PDF »

Endocytosis machinery is involved in aggregation of proteins with expanded polyglutamine domains.

A. B. Meriin, X. Zhang, I. M. Alexandrov, A. B. Salnikova, M. D. Ter-Avanesian, Y. O. Chernoff, and M. Y. Sherman (2007)
FASEB J 21, 1915-1925
 |  Abstract »  |  Full Text »  |  PDF »

A polymorphic glucocorticoid receptor in a mouse population may explain inherited altered stress response and increased anxiety-type behaviors.

D. Xu, A. Buehner, J. Xu, T. Lambert, C. Nekl, M. K. Nielsen, and Y. Zhou (2006)
FASEB J 20, 2414-2416
 |  Abstract »  |  Full Text »  |  PDF »

Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis.

Y. Takeshita, R. Fujinaga, C. Zhao, A. Yanai, and K. Shinoda (2006)
Hum. Mol. Genet. 15, 2298-2312
 |  Abstract »  |  Full Text »  |  PDF »

Biologically active molecules that reduce polyglutamine aggregation and toxicity.

U. A. Desai, J. Pallos, A. A. K. Ma, B. R. Stockwell, L. M. Thompson, J. L. Marsh, and M. I. Diamond (2006)
Hum. Mol. Genet. 15, 2114-2124
 |  Abstract »  |  Full Text »  |  PDF »

Castration Restores Function and Neurofilament Alterations of Aged Symptomatic Males in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy.

E. S. Chevalier-Larsen, C. J. O'Brien, H. Wang, S. C. Jenkins, L. Holder, A. P. Lieberman, and D. E. Merry (2004)
J. Neurosci. 24, 4778-4786
 |  Abstract »  |  Full Text »  |  PDF »

Aggregation of Expanded Polyglutamine Domain in Yeast Leads to Defects in Endocytosis.

A. B. Meriin, X. Zhang, N. B. Miliaras, A. Kazantsev, Y. O. Chernoff, J. M. McCaffery, B. Wendland, and M. Y. Sherman (2003)
Mol. Cell. Biol. 23, 7554-7565
 |  Abstract »  |  Full Text »  |  PDF »

PQBP-1 transgenic mice show a late-onset motor neuron disease-like phenotype.

T. Okuda, H. Hattori, S. Takeuchi, J. Shimizu, H. Ueda, J. J. Palvimo, I. Kanazawa, H. Kawano, M. Nakagawa, and H. Okazawa (2003)
Hum. Mol. Genet. 12, 711-725
 |  Abstract »  |  Full Text »  |  PDF »

Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein.

J. P. Taylor, F. Tanaka, J. Robitschek, C. M. Sandoval, A. Taye, S. Markovic-Plese, and K. H. Fischbeck (2003)
Hum. Mol. Genet. 12, 749-757
 |  Abstract »  |  Full Text »  |  PDF »

Toxic Proteins in Neurodegenerative Disease.

J. P. Taylor, J. Hardy, and K. H. Fischbeck (2002)
Science 296, 1991-1995
 |  Abstract »  |  Full Text »  |  PDF »

Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy.

C. K. Bailey, I. F. M. Andriola, H. H. Kampinga, and D. E. Merry (2002)
Hum. Mol. Genet. 11, 515-523
 |  Abstract »  |  Full Text »  |  PDF »

Protein aggregates and dementia: is there a common toxicity?.

S Lovestone and D M McLoughlin (2002)
J. Neurol. Neurosurg. Psychiatry 72, 152-161
 |  Abstract »  |  Full Text »  |  PDF »

Glucocorticoid modulation of androgen receptor nuclear aggregation and cellular toxicity is associated with distinct forms of soluble expanded polyglutamine protein.

W. J. Welch and M. I. Diamond (2001)
Hum. Mol. Genet. 10, 3063-3074
 |  Abstract »  |  Full Text »  |  PDF »